GoHealth(US:GOCO)2021-03-09 21:42Financial Performance Highlights - GoHealth achieved record revenue of $877 million for FY 2020, representing a 63% increase year-over-year[7, 12] - Adjusted EBITDA for FY 2020 reached $271 million, a 59% increase compared to the previous year[7, 12] - The Adjusted EBITDA margin for FY 2020 was 31%[8, 12] - Q4 2020 revenue was $446 million, a 55% increase year-over-year[12] - Q4 2020 Adjusted EBITDA was $170 million, a 31% increase year-over-year, with a 38% margin[12, 27] Growth and Efficiency - Total submissions for FY 2020 were 730,000, a 71% increase year-over-year[6, 12] - Medicare-Internal segment revenue growth was 110% for FY 2020 and 75% for Q4 2020[12] - The company's commissions receivable balance grew by 112% to $810 million in 2020[29, 31] Outlook for 2021 - Projected revenue for FY 2021 is estimated to be between $1.15 billion and $1.3 billion, representing a growth of 31% to 48%[14] - Adjusted EBITDA for FY 2021 is projected to be between $345 million and $385 million, a growth of 27% to 42%[14] - The Adjusted EBITDA margin for FY 2021 is expected to be around 30%[14]